Career history of Ryszard Kole
Former positions of Ryszard Kole
| Companies | Position | Start | End |
|---|---|---|---|
Ercole Biotech, Inc.
 Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Chief Tech/Sci/R&D Officer | 2000-12-31 | - |
| President | 2000-12-31 | - | |
| The University of North Carolina at Charlotte | Corporate Officer/Principal | - | - |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 2008-04-09 | - |
Training of Ryszard Kole
| Polish Academy of Sciences | Doctorate Degree |
Statistics
International
| United States | 4 |
| Poland | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| President | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Ercole Biotech, Inc.
Ercole Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Sarepta Therapeutics, Inc., Ercole Biotech, Inc. develops splice switching drugs for the treatment of major human diseases. The company is based in Research Triangle Park, NC. The company was founded by Jorn Gorlach. Ercole Biotech was acquired by Sarepta Therapeutics, Inc. on March 20, 2008 for $8.25 million. | Commercial Services |
- Stock Market
- Insiders
- Ryszard Kole
- Experience
